<?xml version="1.0" encoding="utf-8"?>
<rss xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<atom:link rel="self" href="http://podcast.peerviewpress.com/cardiology/cardiologychannel.xml" type="application/rss+xml" />
		<lastBuildDate>Thu, 02 Jul 2009 15:09:16 -0400</lastBuildDate>
		<title>PeerView Cardiology CME/CNE/CPE Audio Podcast</title>
		<itunes:author>PeerView Press</itunes:author>
		<link>http://www.peerviewpress.com</link>
		<generator>Podcast Maker v1.3.8b - http://www.lemonzdream.com/podcastmaker</generator>
		<description><![CDATA[PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.]]></description>
		<itunes:subtitle>Thought leader perspectives on current clinical advances in medicine</itunes:subtitle>
		<itunes:summary>PeerView Press is an independent, professional medical publishing company focused on gathering and reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. As publishers of PeerView Publications, PeerView Press is solely responsible for the selection of publication topics, the preparation of editorial content and the distribution of all materials it publishes.</itunes:summary>
		<language>en-us</language>
		<copyright>2006</copyright>
		<itunes:owner>
			<itunes:name>PeerView Press, 24 West 40th Street, Suite 950, New York, NY 10018</itunes:name>
			<itunes:email>webmaster@peerviewpress.com</itunes:email>
		</itunes:owner>
		<image>
			<url>http://podcast.peerviewpress.com/cardiology/podcast_CardiologyCME-CNE-CPE_144.jpg</url>
			<title>PeerView Cardiology CME/CNE/CPE Audio Podcast</title>
			<link>http://www.peerviewpress.com</link>
			<width>144</width>
			<height>144</height>
		</image>
		<itunes:image href="http://podcast.peerviewpress.com/cardiology/podcast_CardiologyCME-CNE-CPE.jpg" />
		<category>Science &amp; Medicine</category>
		<itunes:category text="Science &amp; Medicine" />
		<itunes:keywords>CME, Medical Education, continuing medical education, CME credits, PeerView Press, inSession, inReview, CE, Cardiology</itunes:keywords>
		<itunes:explicit>no</itunes:explicit>
		<item>
			<title>Robert C. Bourge, MD - State of the Art in Pulmonary Arterial Hypertension</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, an expert in PAH discusses signs and symptoms, diagnostic procedures, and optimal treatment approaches, including combination strategies, in patients with the condition.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, an expert in PAH discusses signs and symptoms, diagnostic procedures, and optimal treatment approaches, including combination strategies, in patients with the condition.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/cardiology/PA04897FCn210.mp3" length="17599953" />
			<link>http://podcast.peerviewpress.com/cardiology/PA04897FCn210.mp3</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA04897FCn210.mp3</guid>
			<pubDate>Wed, 17 Jun 2009 15:04:03 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:24:23</itunes:duration>
			<itunes:keywords>pulmonary arterial hypertension, PAH</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - State of the Art in Pulmonary Arterial Hypertension</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/cardiology/PA04897FCCMEinfo.pdf" length="704941" />
			<link>http://podcast.peerviewpress.com/cardiology/PA04897FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA04897FCCMEinfo.pdf</guid>
			<pubDate>Wed, 17 Jun 2009 15:04:01 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>pulmonary arterial hypertension, PAH</itunes:keywords>
		</item>
		<item>
			<title>Stuart J. Connolly, MD, FRCPC - The Evolving Role of Antiplatelet Therapy for Atrial Fibrillation: Highlights From the ACC Scientific Sessions 2009</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in management of stroke prevention in patients with atrial fibrillation discuss challenges and controversies with the current standard of care for stroke prevention and analyze emerging options for stroke prevention.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in management of stroke prevention in patients with atrial fibrillation discuss challenges and controversies with the current standard of care for stroke prevention and analyze emerging options for stroke prevention.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/cardiology/PI04851FC_s551.mp3" length="26950264" />
			<link>http://podcast.peerviewpress.com/cardiology/PI04851FC_s551.mp3</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PI04851FC_s551.mp3</guid>
			<pubDate>Tue, 16 Jun 2009 14:16:43 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:28:02</itunes:duration>
			<itunes:keywords>atrial fibrillation, stroke, stroke prevention, antiplatelet therapy, anticoagulation, vitamin K antagonists</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - The Evolving Role of Antiplatelet Therapy for Atrial Fibrillation: Highlights From the ACC Scientific Sessions 2009</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/cardiology/PI04851FCCMEinfo.pdf" length="312849" />
			<link>http://podcast.peerviewpress.com/cardiology/PI04851FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PI04851FCCMEinfo.pdf</guid>
			<pubDate>Tue, 16 Jun 2009 14:16:41 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>atrial fibrillation, stroke, stroke prevention, antiplatelet therapy, anticoagulation, vitamin K antagonists</itunes:keywords>
		</item>
		<item>
			<title>Jean-Michel Molina, MD, PhD - An Individualized Approach to Selecting Initial Antiretroviral Regimens</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the management of HIV discuss the clinical implications of recent developments for initial therapy of HIV. ]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the management of HIV discuss the clinical implications of recent developments for initial therapy of HIV. </itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/cardiology/PPVNE05388r448.mp3" length="25050129" />
			<link>http://podcast.peerviewpress.com/cardiology/PPVNE05388r448.mp3</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PPVNE05388r448.mp3</guid>
			<pubDate>Fri, 29 May 2009 15:21:26 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:26:03</itunes:duration>
			<itunes:keywords>HIV, ART, antiretroviral, PI, protease inhibitor, NNRTI, treatment-naïve</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - An Individualized Approach to Selecting Initial Antiretroviral Regimens</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/cardiology/PPVNE05388CMEinfo.pdf" length="728287" />
			<link>http://podcast.peerviewpress.com/cardiology/PPVNE05388CMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PPVNE05388CMEinfo.pdf</guid>
			<pubDate>Fri, 29 May 2009 15:21:24 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>HIV, ART, antiretroviral, PI, protease inhibitor, NNRTI, treatment-naïve</itunes:keywords>
		</item>
		<item>
			<title>Vivian A. Fonseca, MD, FRCP - Matching Treatment to Need in Type 2 Diabetes: Using Incretin-Based Oral Therapies Across the Clinical Spectrum</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, an expert in diabetes discusses optimal management strategies in a diabetic patient who has been failing standard therapy and in a treatment-naïve diabetic patient with renal impairment. Other specific challenges, such as minimizing the risk of hypoglycemia, are also explored.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, an expert in diabetes discusses optimal management strategies in a diabetic patient who has been failing standard therapy and in a treatment-naïve diabetic patient with renal impairment. Other specific challenges, such as minimizing the risk of hypoglycemia, are also explored.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/cardiology/PA05738FCp156.mp3" length="35084573" />
			<link>http://podcast.peerviewpress.com/cardiology/PA05738FCp156.mp3</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA05738FCp156.mp3</guid>
			<pubDate>Thu, 21 May 2009 14:52:25 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:36:30</itunes:duration>
			<itunes:keywords>diabetes, glycemic control, A1C, incretin</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - Matching Treatment to Need in Type 2 Diabetes: Using Incretin-Based Oral Therapies Across the Clinical Spectrum</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/cardiology/PA05738FCCMEinfo.pdf" length="737562" />
			<link>http://podcast.peerviewpress.com/cardiology/PA05738FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA05738FCCMEinfo.pdf</guid>
			<pubDate>Thu, 21 May 2009 14:52:23 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>diabetes, glycemic control, A1C, incretin</itunes:keywords>
		</item>
		<item>
			<title>John G. Bartlett, MD - DHHS Guidelines Update: Improving Outcomes in HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the management of HIV discuss the clinical implications of the latest updates to the DHHS guidelines.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the management of HIV discuss the clinical implications of the latest updates to the DHHS guidelines.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/cardiology/PA05393FCr439.mp3" length="25455491" />
			<link>http://podcast.peerviewpress.com/cardiology/PA05393FCr439.mp3</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA05393FCr439.mp3</guid>
			<pubDate>Tue, 21 Apr 2009 15:19:41 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:26:28</itunes:duration>
			<itunes:keywords>HIV; DHHS guidelines; HIV guidelines; ART; antiretroviral therapy</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - DHHS Guidelines Update: Improving Outcomes in HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/cardiology/PA05393FCCMEinfo.pdf" length="705917" />
			<link>http://podcast.peerviewpress.com/cardiology/PA05393FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA05393FCCMEinfo.pdf</guid>
			<pubDate>Tue, 21 Apr 2009 15:19:39 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>HIV; DHHS guidelines; HIV guidelines; ART; antiretroviral therapy</itunes:keywords>
		</item>
		<item>
			<title>Louis Monnier, MD - A Debate on Glycaemic Control in Type 2 Diabetes: Maintaining Target A1c, Postmeal Glucose, and Therapy Selection</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the management of type 2 diabetes discuss the role of postprandial hyperglycaemia in achieving optimal glycaemic control and reducing the risk of cardiovascular events.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the management of type 2 diabetes discuss the role of postprandial hyperglycaemia in achieving optimal glycaemic control and reducing the risk of cardiovascular events.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/cardiology/PI04742FCe025.mp3" length="43735058" />
			<link>http://podcast.peerviewpress.com/cardiology/PI04742FCe025.mp3</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PI04742FCe025.mp3</guid>
			<pubDate>Thu, 16 Apr 2009 15:42:12 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:45:31</itunes:duration>
			<itunes:keywords>type 2 diabetes, hyperglycaemia, hypoglycaemia, postprandial glucose, glycaemic control,  monitoring, cardiovascular disease</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - A Debate on Glycaemic Control in Type 2 Diabetes: Maintaining Target A1c, Postmeal Glucose, and Therapy Selection</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/cardiology/PI04742FCCMEinfo.pdf" length="304013" />
			<link>http://podcast.peerviewpress.com/cardiology/PI04742FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PI04742FCCMEinfo.pdf</guid>
			<pubDate>Thu, 16 Apr 2009 15:42:10 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>type 2 diabetes, hyperglycaemia, hypoglycaemia, postprandial glucose, glycaemic control,  monitoring, cardiovascular disease</itunes:keywords>
		</item>
		<item>
			<title>Edith A. Perez, MD - Finding Ways to Prevent, Circumvent, or Overcome Cardiovascular Toxicity Associated With Modern Breast Cancer Therapies</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in breast cancer discuss current evidence on the risk of cardiotoxicity associated with various breast cancer therapies and provide practical recommendations for preventing, monitoring and managing cardiovascular adverse effects in patients undergoing treatment for breast cancer.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in breast cancer discuss current evidence on the risk of cardiotoxicity associated with various breast cancer therapies and provide practical recommendations for preventing, monitoring and managing cardiovascular adverse effects in patients undergoing treatment for breast cancer.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/cardiology/PA05378FCr430.mp3" length="19967405" />
			<link>http://podcast.peerviewpress.com/cardiology/PA05378FCr430.mp3</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA05378FCr430.mp3</guid>
			<pubDate>Mon, 06 Apr 2009 15:02:01 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:20:45</itunes:duration>
			<itunes:keywords>breast cancer, cardiotoxicity, trastuzumab, HERA, CHF, hypertension, cardiac events, LVEF, anthracyclines</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - Finding Ways to Prevent, Circumvent, or Overcome Cardiovascular Toxicity Associated With Modern Breast Cancer Therapies</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat reader software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/cardiology/PA05378FCCMEinfo.pdf" length="726638" />
			<link>http://podcast.peerviewpress.com/cardiology/PA05378FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA05378FCCMEinfo.pdf</guid>
			<pubDate>Mon, 06 Apr 2009 15:01:59 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>breast cancer, cardiotoxicity, trastuzumab, HERA, CHF, hypertension, cardiac events, LVEF, anthracyclines</itunes:keywords>
		</item>
		<item>
			<title>William A. O’Brien, MD - Treatment Guideline Update: Improving Cardiovascular and Metabolic Outcomes in Patients With HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, two leading experts in the area of HIV management will analyze the latest treatment guidelines for managing metabolic and cardiovascular risk in patients with HIV. Topics in these discussions include cardiovascular and metabolic considerations for individualizing therapy, treatment selection, and insight regarding switching therapies. In addition, practical considerations for the screening, monitoring, and management of these comorbidities in patients with HIV will be discussed.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, two leading experts in the area of HIV management will analyze the latest treatment guidelines for managing metabolic and cardiovascular risk in patients with HIV. Topics in these discussions include cardiovascular and metabolic considerations for individualizing therapy, treatment selection, and insight regarding switching therapies. In addition, practical considerations for the screening, monitoring, and management of these comorbidities in patients with HIV will be discussed.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/cardiology/PA04256FCr431.mp3" length="29494747" />
			<link>http://podcast.peerviewpress.com/cardiology/PA04256FCr431.mp3</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA04256FCr431.mp3</guid>
			<pubDate>Tue, 24 Mar 2009 14:42:21 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:30:41</itunes:duration>
			<itunes:keywords>HIV; DHHS guidelines; guidelines; ART; antiretroviral therapy; cardiovascular risk; metabolic syndrome</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - Treatment Guideline Update: Improving Cardiovascular and Metabolic Outcomes in Patients With HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/cardiology/PA04256FCCMEinfo.pdf" length="727769" />
			<link>http://podcast.peerviewpress.com/cardiology/PA04256FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA04256FCCMEinfo.pdf</guid>
			<pubDate>Tue, 24 Mar 2009 14:42:18 -0400</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>HIV; DHHS guidelines; guidelines; ART; antiretroviral therapy; cardiovascular risk; metabolic syndrome</itunes:keywords>
		</item>
		<item>
			<title>Deepak L. Bhatt, MD, MPH - What Clinicians Need To Know About Antiplatelet Therapy and Managing Acute Coronary Syndrome: A Roundtable Discussion</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in acute coronary syndrome discuss the latest guidelines on antiplatelet therapy and how to improve outcomes for their patients with ACS.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CNE/CPE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in acute coronary syndrome discuss the latest guidelines on antiplatelet therapy and how to improve outcomes for their patients with ACS.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/cardiology/PA05183FCe024.mp3" length="20784524" />
			<link>http://podcast.peerviewpress.com/Cardiology/PA05183FCe024.mp3</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA05183FCe024.mp3</guid>
			<pubDate>Mon, 12 Jan 2009 15:48:52 -0500</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:21:36</itunes:duration>
			<itunes:keywords>acute coronary syndrome, antiplatelet therapy, cardiovascular risk, bleeding, percutaneous intervention, stents, diabetes, hypertension, clopidogrel</itunes:keywords>
		</item>
		<item>
			<title>CME/CNE/CPE Information - What Clinicians Need To Know About Antiplatelet Therapy and Managing Acute Coronary Syndrome: A Roundtable Discussion</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CNE/CPE information. You will need Adobe Acrobat software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/cardiology/PA05183FCCMEinfo.pdf" length="714371" />
			<link>http://podcast.peerviewpress.com/Cardiology/PA05183FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA05183FCCMEinfo.pdf</guid>
			<pubDate>Mon, 12 Jan 2009 15:48:48 -0500</pubDate>
			<category>Science, Medicine</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>acute coronary syndrome, antiplatelet therapy, cardiovascular risk, bleeding, percutaneous intervention, stents, diabetes, hypertension, clopidogrel</itunes:keywords>
		</item>
		<item>
			<title>Christie Mitchell Ballantyne, MD - Comprehensive Management of Patients With Atherosclerotic Disease</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[This program is designed to help minimize cardiovascular risk in patients with dyslipidemia. The three expert panelists discuss the value of aggressive goals for LDL-C and blood pressure, managing patients with comorbidities, and strategies for helping patients reach and stay at treatment goals.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>This program is designed to help minimize cardiovascular risk in patients with dyslipidemia. The three expert panelists discuss the value of aggressive goals for LDL-C and blood pressure, managing patients with comorbidities, and strategies for helping patients reach and stay at treatment goals.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/cardiology/PA04420FCe021.mp3" length="45108069" />
			<link>http://podcast.peerviewpress.com/cardiology/PA04420FCe021.mp3</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA04420FCe021.mp3</guid>
			<pubDate>Thu, 16 Oct 2008 14:54:47 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:46:54</itunes:duration>
			<itunes:keywords>dyslipidemia, cardiovascular risk, hypertension, atherosclerosis, diabetes, low-density cholesterol, statin, ezetimibe, colesevalam, metabolic syndrome</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Comprehensive Management of Patients With Atherosclerotic Disease</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information.  You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information.  You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information.  You will need Adobe Acrobat reader software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/cardiology/PA04420FCCMEinfo.pdf" length="339919" />
			<link>http://podcast.peerviewpress.com/cardiology/PA04420FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA04420FCCMEinfo.pdf</guid>
			<pubDate>Thu, 16 Oct 2008 14:54:31 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>dyslipidemia, cardiovascular risk, hypertension, atherosclerosis, diabetes, low-density cholesterol, statin, ezetimibe, colesevalam, metabolic syndrome</itunes:keywords>
		</item>
		<item>
			<title>Donald P. Kotler, MD - Understanding Metabolic Dysfunction in HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts review the association between HIV disease, antiretroviral therapy, and the risk for metabolic dysfunction in patients with HIV. A review of the most appropriate management strategies for metabolic dysfunction in this patient population is featured.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file or full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts review the association between HIV disease, antiretroviral therapy, and the risk for metabolic dysfunction in patients with HIV. A review of the most appropriate management strategies for metabolic dysfunction in this patient population is featured.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/cardiology/PA04255FCr403.mp3" length="23749187" />
			<link>http://podcast.peerviewpress.com/cardiology/PA04255FCr403.mp3</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA04255FCr403.mp3</guid>
			<pubDate>Thu, 31 Jul 2008 15:16:07 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:24:39</itunes:duration>
			<itunes:keywords>HIV, metabolic syndrome, cardiovascular disease, ATAZIP, COMET, SWEET, dyslipidemia, PI, atherosclerosis, NNRTI, HAART, BICOMBO</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Understanding Metabolic Dysfunction in HIV</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file or full CME/CE information. You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary />
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/cardiology/PA04255FCCMEinfo.pdf" length="281021" />
			<link>http://podcast.peerviewpress.com/cardiology/PA04255FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA04255FCCMEinfo.pdf</guid>
			<pubDate>Thu, 31 Jul 2008 15:16:06 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>HIV, metabolic syndrome, cardiovascular disease, ATAZIP, COMET, SWEET, dyslipidemia, PI, atherosclerosis, NNRTI, HAART, BICOMBO</itunes:keywords>
		</item>
		<item>
			<title>Michael A. Weber, MD - Improving Outcomes in Hypertension and Congestive Heart Failure: Focus on New Generation Beta-Blockers</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this CME activity, an expert in the management of hypertension and congestive heart failure discusses recent data on the vasodilatory beta-blockers in the treatment of both conditions. The differences between conventional and vasodilatory beta-blockers are also highlighted.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this CME activity, an expert in the management of hypertension and congestive heart failure discusses recent data on the vasodilatory beta-blockers in the treatment of both conditions. The differences between conventional and vasodilatory beta-blockers are also highlighted.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/cardiology/PA04119FCn179.mp3" length="16849908" />
			<link>http://podcast.peerviewpress.com/cardiology/PA04119FCn179.mp3</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA04119FCn179.mp3</guid>
			<pubDate>Fri, 25 Apr 2008 10:44:11 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:17:28</itunes:duration>
			<itunes:keywords>Beta-blockers, nebivolol, carvedilol, hypertension, CHF, heart failure, nitric oxide, vasodilation, CAPRICORN, SENIORS, blood pressure</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Improving Outcomes in Hypertension and Congestive Heart Failure: Focus on New Generation Beta-Blockers</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information.  You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information.  You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information.  You will need Adobe Acrobat reader software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/cardiology/PA04119FCCMEinfo.pdf" length="213021" />
			<link>http://podcast.peerviewpress.com/cardiology/PA04119FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA04119FCCMEinfo.pdf</guid>
			<pubDate>Fri, 25 Apr 2008 10:43:58 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>Beta-blockers, nebivolol, carvedilol, hypertension, CHF, heart failure, nitric oxide, vasodilation, CAPRICORN, SENIORS, blood pressure</itunes:keywords>
		</item>
		<item>
			<title>Deepak L. Bhatt, MD - Preventing Thrombotic Complications After Percutaneous Coronary Intervention: An Update for Cardiologists</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, experts in the management of acute coronary syndrome (ACS) describe the rationale and updated guidelines supporting the long-term use of dual antithrombotic therapy in patients who have undergone percutaneous coronary intervention (PCI) with stent placement. In addition, limitations regarding the pharmacokinetics of clopidogrel in this context lay the foundation for the discussion of novel antithrombotic agents in development.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, experts in the management of acute coronary syndrome (ACS) describe the rationale and updated guidelines supporting the long-term use of dual antithrombotic therapy in patients who have undergone percutaneous coronary intervention (PCI) with stent placement. In addition, limitations regarding the pharmacokinetics of clopidogrel in this context lay the foundation for the discussion of novel antithrombotic agents in development.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/cardiology/PA04288FCr370.mp3" length="32803019" />
			<link>http://podcast.peerviewpress.com/Pulmonology/PA04288FCr370.mp3</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA04288FCr370.mp3</guid>
			<pubDate>Fri, 07 Mar 2008 14:55:55 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:34:05</itunes:duration>
			<itunes:keywords>Acute coronary syndrome, angioplasty, PCI, clopidogrel, aspirin, stent, paclitaxel-eluting, sirolimus-eluting, bare metal</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Preventing Thrombotic Complications After Percutaneous Coronary Intervention: An Update for Cardiologists</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information.  You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information.  You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information.  You will need Adobe Acrobat reader software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/cardiology/PA04288FCCMEinfo.pdf" length="213813" />
			<link>http://podcast.peerviewpress.com/cardiology/PA04288FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA04288FCCMEinfo.pdf</guid>
			<pubDate>Fri, 07 Mar 2008 14:54:56 -0500</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>Acute coronary syndrome, angioplasty, PCI, clopidogrel, aspirin, stent, paclitaxel-eluting, sirolimus-eluting, bare metal</itunes:keywords>
		</item>
		<item>
			<title>Vallerie McLaughlin, MD - Pulmonary Arterial Hypertension: A Case-Based Approach to Recognition and Management</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this interactive activity, an expert in the management of pulmonary arterial hypertension (PAH) presents three cases, by examining criteria that establish clinical status and the diagnosis of PAH. In addition, clinical-trial data are presented regarding the efficacy and safety of available and emerging therapies for this condition. ]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this interactive activity, an expert in the management of pulmonary arterial hypertension (PAH) presents three cases, by examining criteria that establish clinical status and the diagnosis of PAH. In addition, clinical-trial data are presented regarding the efficacy and safety of available and emerging therapies for this condition. </itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/cardiology/PA03751FCp115.mp3" length="52390186" />
			<link>http://podcast.peerviewpress.com/Pulmonology/PA03751FCp115.mp3</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA03751FCp115.mp3</guid>
			<pubDate>Wed, 15 Aug 2007 16:56:19 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:54:28</itunes:duration>
			<itunes:keywords>6-minute–walk distance, Ambrisentan, Bosentan, Cardiac catheterization,Echocardiography,endothelin-receptor antagonists,Epoprostenol,Hypertension, pulmonary arterial,Iloprost,Phosphodiesterase inhibitor,Prostacyclin,Raynaud’s phenomenon,Scleroderma</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Pulmonary Arterial Hypertension: A Case-Based Approach to Recognition and Management</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information.  You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information.  You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information.  You will need Adobe Acrobat reader software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/cardiology/PA03751FCCMEp115.pdf" length="98557" />
			<link>http://podcast.peerviewpress.com/Pulmonology/PA03751FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA03751FCCMEp115.pdf</guid>
			<pubDate>Wed, 15 Aug 2007 16:56:11 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>6-minute–walk distance, Ambrisentan, Bosentan, Cardiac catheterization,Echocardiography,endothelin-receptor antagonists,Epoprostenol,Hypertension, pulmonary arterial,Iloprost,Phosphodiesterase inhibitor,Prostacyclin,Raynaud’s phenomenon,Scleroderma</itunes:keywords>
		</item>
		<item>
			<title>Benjamin Ansell, MD - Optimal Reduction of Cardiovascular Risk With Statin Therapy:
A Case-Based Approach</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, an expert will employ a case-based format to discuss strategies for assessing a patient’s risk for coronary heart disease (CHD) and optimally reducing the odds of CHD development in those with elevated risk.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, an expert will employ a case-based format to discuss strategies for assessing a patient’s risk for coronary heart disease (CHD) and optimally reducing the odds of CHD development in those with elevated risk.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/cardiology/PA03593FCp116.mp3" length="29972641" />
			<link>http://podcast.peerviewpress.com/cardiology/PA03593FCp116.mp3</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA03593FCp116.mp3</guid>
			<pubDate>Fri, 01 Jun 2007 14:06:27 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:31:08</itunes:duration>
			<itunes:keywords>Type 2 diabetes mellitus, LDL-C, HDL-C, total cholesterol, triglycerides, non-HDL-C, hypertension, dyslipidemia, rosuvastatin, atorvastatin, simvastatin, pravastatin, fenofibrate, ezetimibe, niacin-ER, ATP III, NCEP, coronary heart disease, CHD, CVD, TLC</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Optimal Reduction of Cardiovascular Risk With Statin Therapy:
A Case-Based Approach</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information.  You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information.  You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information.  You will need Adobe Acrobat reader software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/cardiology/PA03593FCCMEinfo.pdf" length="409098" />
			<link>http://podcast.peerviewpress.com/cardiology/PA03593FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA03593FCCMEinfo.pdf</guid>
			<pubDate>Fri, 01 Jun 2007 14:05:58 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>Type 2 diabetes mellitus, LDL-C, HDL-C, total cholesterol, triglycerides, non-HDL-C, hypertension, dyslipidemia, rosuvastatin, atorvastatin, simvastatin, pravastatin, fenofibrate, ezetimibe, niacin-ER, ATP III, NCEP, coronary heart disease, CHD, CVD, TLC</itunes:keywords>
		</item>
		<item>
			<title>Steven Steinhubl, MD - Limitations of Current Antiplatelet Therapy With PCI: Focus on Novel Therapies in Development</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[In this activity, expert cardiologists discuss the updated standard for prescribing antiplatelet therapy to avert subacute and long-term thrombotic complications associated with PCI and stent placement. In addition, the clinical development of pharmacologically distinctive antiplatelet agents is discussed.]]></description>
			<itunes:subtitle>Please be sure to view the accompanying (PDF) file for full CME/CE information.</itunes:subtitle>
			<itunes:summary>In this activity, expert cardiologists discuss the updated standard for prescribing antiplatelet therapy to avert subacute and long-term thrombotic complications associated with PCI and stent placement. In addition, the clinical development of pharmacologically distinctive antiplatelet agents is discussed.</itunes:summary>
			<enclosure type="audio/mpeg" url="http://www.podtrac.com/pts/redirect.mp3?http://podcast.peerviewpress.com/cardiology/PA03752FCr291.mp3" length="27147237" />
			<link>http://podcast.peerviewpress.com/cardiology/PA03752FCr291.mp3</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA03752FCr291.mp3</guid>
			<pubDate>Mon, 30 Apr 2007 16:07:47 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:28:11</itunes:duration>
			<itunes:keywords>Antiplatelet, Aspirin, AZD6140, Cangrelor, Clopidogrel, NSTEMI, Percutaneous coronary intervention (PCI), Platelet inhibition, Prasugrel, STEMI, Stent, Stent, bare-metal, Stent, drug-eluting, Thienopyridines, Thrombosis, coronary, Ticlopidine</itunes:keywords>
		</item>
		<item>
			<title>CME/CE Information - Limitations of Current Antiplatelet Therapy With PCI: Focus on Novel Therapies in Development</title>
			<itunes:author>PVI, PeerView Institute for Medical Education</itunes:author>
			<description><![CDATA[Please view this PDF file for full CME/CE information.  You will need Adobe Acrobat reader software to access this file.]]></description>
			<itunes:subtitle>Please view this PDF file for full CME/CE information.  You will need Adobe Acrobat reader software to access this file.</itunes:subtitle>
			<itunes:summary>Please view this PDF file for full CME/CE information.  You will need Adobe Acrobat reader software to access this file.</itunes:summary>
			<enclosure type="application/pdf" url="http://podcast.peerviewpress.com/cardiology/PA03752FCCMEinfo.pdf" length="101276" />
			<link>http://podcast.peerviewpress.com/cardiology/PA03752FCCMEinfo.pdf</link>
			<guid>http://podcast.peerviewpress.com/cardiology/PA03752FCCMEinfo.pdf</guid>
			<pubDate>Mon, 30 Apr 2007 16:07:40 -0400</pubDate>
			<category>Science</category>
			<itunes:explicit>no</itunes:explicit>
			<itunes:duration>00:00:00</itunes:duration>
			<itunes:keywords>Antiplatelet, Aspirin, AZD6140, Cangrelor, Clopidogrel, NSTEMI, Percutaneous coronary intervention (PCI), Platelet inhibition, Prasugrel, STEMI, Stent, Stent, bare-metal, Stent, drug-eluting, Thienopyridines, Thrombosis, coronary, Ticlopidine</itunes:keywords>
		</item>
	</channel>
</rss>